GDC-0425

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GDC-0425, covering 2017-04-12 to 2017-04-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma [Phase 1]

See pricing